Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9274109

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9272009

    Method for increasing performance of offspring

    JBS UNITED, INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9271937

    Oxidized cellulose microspheres

    Covidien LP · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9273288

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9271901

    One-part dental adhesive composition

    KURARAY NORITAKE DENTAL INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9273284

    Method for generating potent dendritic cells

    The Regents of the University of California · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9273315

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9273191

    Medical devices with an activated coating

    Covidien LP · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9273136

    Fully human anti-human NKG2D monoclonal antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9273124

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9273093

    α4β7 peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9273121

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9273076

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9272991

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9272978

    Hydroxy acid ester compound of substituted phenol, preparation method and medical use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9272055

    Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

    The Regents of the University of California · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9272051

    Methods and systems for modulating hormones and related methods, agents and compositions

    The United States Government represented by the Department of Veterans Affairs · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9272044

    Injectable flowable composition buprenorphine

    Indivior UK Limited · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9272034

    Treatment of conditions related to shock

    The Regents of the University of California · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9272027

    Francisella tularensis live vaccine strains and methods of use

    United States of America as represented by the Secretary of the Air Force · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9271962

    Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

    Northwestern University · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9271985

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9271965

    Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

    Theravance Biopharma R&D IP, LLC · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9271950

    Compositions for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. EP 2988750

    VERWENDUNG VON LANDIOLOLHYDROCHLORID BEI DER LANGZEITBEHANDLUNG VON TACHYARRHYTHMIEN

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Wed Mar 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Feb 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9278901

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9278066

    Topical pharmaceutical foam composition

    Precision Dermatology, Inc. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9278091

    Compounds for the treatment of Clostridium difficile associated disease

    SUMMIT THERAPEUTICS PLC · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9278116

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9277799

    Henna applicator device and a method of operating the same

    UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9279366

    Steam powered engine

    SPINDYNE LLC · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9279009

    FILIP1L nucleic acid fragments

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9279019

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9278923

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9278942

    Non-steroidal compounds as androgen receptor modulators

    FLX Discoveries Oy · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9278931

    Cyclopropaneamine compound

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9278161

    Tissue-separating fatty acid adhesion barrier

    ATRIUM MEDICAL CORPORATION · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9278112

    Citrate containing beverage

    The Regents of the University of California · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9278921

    Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

    QUANTUM GENOMICS · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9278125

    Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

    Sanaria Inc. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9278124

    Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

    HALOZYME, INC. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9278110

    Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

    UNITED PHARMACEUTICALS · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9278113

    Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof

    The Board of Regents of the University of Texas System · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9278096

    Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity

    Takeda Pharmaceuticals North America, Inc. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9278090

    Methods of preventing the development of mucositis and related disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9278068

    Vesicle compositions

    The Board of Regents of the University of Texas System · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.